Connect with us

Business

Gap Q2 2026 earnings

Published

on

Gap Q2 2026 earnings

Gap on Thursday announced a new CEO for its Old Navy banner, effective Nov. 2, as the retailer tries to reinvigorate sluggish sales performance at the brand.

Michael Francis, who was appointed the chief customer officer at Old Navy in May, will take over the reins from current CEO Haio Barbeito, who will become an advisor to the company. Barbeito has held the position since 2022.

Gap CEO Richard Dickson told CNBC the move was “a planned and thoughtful transition” to better equip Old Navy for its next chapter.

“We’ve been working — from fixing fundamentals to building momentum and ultimately looking to accelerate growth, and so there’s not a change in strategy,” Dickson said in an interview. “We’re just going to continue to execute better, continuously improve our core business, while we drive some accelerators that we’re really excited about.”

Advertisement

Shares of Gap jumped 12% in extended trading Thursday.

In the company’s fiscal second-quarter earnings report, Old Navy posted net sales of $2.1 billion — down 4% year over year. Comparable sales were also down 4%, versus comparable sales growth of 2% during the same period last year. Wall Street analysts were expecting a decline of 2.4% for the most recent period, according to StreetAccount.

It marked Old Navy’s first negative same-store sales figure since the second quarter of 2023 and was due in part to “unanticipated slowdown in traffic,” the company said. The brand contributes nearly 60% to Gap’s overall revenue.

Dickson told CNBC that Old Navy specifically saw disappointing results from its summer marketing, which he said “lacked a direct product message.” But he added that the brand has already begun to see “significant improvement” in its traffic and sales this past month.

Advertisement

Incoming CEO Francis said in a statement the brand would “continue to sharpen our customer focus, strengthen the brand’s cultural relevance, enhance the customer experience across every touchpoint and build on the momentum already underway.”

Overall, Gap reported mixed results for its fiscal second quarter, beating analysts’ estimates for earnings per share but underperforming revenue expectations. Gap Inc. comparable sales were down 1% for the period, including a 3% year-over-year decline in in-store sales.

“Ultimately, our slight miss on total company was really due to Old Navy’s seasonal product assortment,” Dickson said. “We know we didn’t execute well on our seasonal product, but if there’s good news in this, seasonal is behind us.”

For the full fiscal year, Gap narrowed its net sales growth outlook from a range of between 1% and 2% to a range of between 1% to 1.5% due to the lag at Old Navy. Still, the company hiked its expectations for adjusted earnings per share from a range of $2.30 to $2.40 for the full year to a range of $2.35 to $2.45.

Advertisement

Here’s how the company performed in the quarter ended Aug. 1 compared with what Wall Street was expecting, according to a survey of analysts by LSEG:

  • Earnings per share: 52 cents adjusted vs. 48 cents expected
  • Revenue: $3.65 billion vs. $3.69 billion expected

Gap reported net income of $501 million, or $1.38 per share, compared with $216 million, or 57 cents per share, the prior year. Sales sank slightly to $3.65 billion from $3.73 billion in the year-ago period.

Adjusting for one-time items — in particular the impact of tariff refunds of approximately $512 million — Gap reported earnings per share of 52 cents.

“On balance, we’re running a very disciplined organization with a playbook that is working,” Dickson said. “These things take time. I think, pointing to Gap as the lead success story of our playbook, you can see the ability for us to actually deliver relevance and revenue, and we’re well on our way.”

At the namesake Gap banner, comparable sales soared 10% for the quarter — outpacing Wall Street expectations of 8.6% growth — and net sales jumped 9% to $844 million. The company attributed those gains to “culturally relevant storytelling” in categories across denim, fleece and kids and baby.

Advertisement

As for Gap’s other brands, Banana Republic saw its comparable sales up 3% for the quarter, with net sales reaching $478 million. Analysts were expecting comparable sales up 2%, according to consensus metrics from StreetAccount. The company said the brand “continued to make progress” in its assortment during the quarter.

And, Athleta’s comparable sales sank 12% for the quarter, hitting net sales of just $264 million. Gap said that Athleta “remains focused on disciplined execution to rebuild the brand profitably.”

The company also said a significant increase in gross margin during the fiscal second quarter was the result of a 11.4-percentage-point benefit from “expected recovery of tariffs.” Absent that tariff impact, Gap’s gross margin improved by 0.2% year over year.

Gap said it received $95 million of tariff refunds during the quarter and used the funds to lower the costs of some of its products. The remainder of its tariff refund is expected in the third quarter, the company said.

Advertisement

Dickson added that the company continues to see a “resilient but discerning” consumer with sales growth across all income cohorts.

Continue Reading
Click to comment

You must be logged in to post a comment Login

Leave a Reply

Business

PM call to keep refugee numbers ‘not a backflip’

Published

on

PM call to keep refugee numbers 'not a backflip'

Yes. Corporate subscriptions are available for teams and organisations, with discounted rates as user numbers increase. Pricing starts from $1,625 + GST per user.
Get in touch
to discuss the right option for your organisation.

Business News subscriptions are used by executives, investors, consultants and professionals who need to stay informed and make better decisions about the WA market. When you subscribe you’ll get

  • Unlimited access to WA’s most trusted business journalism
  • Data & Insights — detailed profiles of WA companies, people, projects and deals
  • MyBN — a personalised feed based on the companies, people and sectors you follow
  • Special publications and industry reports
  • Daily and weekly email newsletters

Data & Insights is a research tool built specifically for the WA market. It draws on more than 30 years of Business News reporting, updated regularly to reflect what’s happening now. Use it to:

  • Look up detailed profiles of WA companies, including financials, directors and ownership
  • Find decision-makers and track their career movements
  • Research live and completed projects across WA industries
  • Monitor deals, appointments and market activity
  • Access industry rankings and league tables

Data & Insights is updated daily by our dedicated research team, which uses the latest announcements, ASX filings and editorial coverage to keep our person, company, list and project records up to date.

Business News welcome all opportunities to make our dataset accurate, complete and current, so if you have an update request, please email the team at
general@businessnews.com.au, and we’d be happy to assist.

Advertisement

MyBN
is part of every subscription. It’s your personalised view of Business News. You can follow the companies, people, sectors and projects that matter to you, and get a news feed and alerts tailored to your interests. You can save articles to read later and retain only what you need.

Only subscribers have full access to all content on the Business News website.

Advertisement

If staying informed about the WA economy is part of your job, and/or you’re looking for networking opportunities in WA, Business News is built for you.

Business News subscribers are:

  • Executives and directors tracking competitors, clients and market movements
  • Investors and advisers researching companies, deals and industry trends
  • Consultants and professionals staying across sectors relevant to their clients
  • Business owners looking for leads, context and market intelligence

Most Business News publications cover national or global markets. Business News is focused entirely on Western Australia, which means the journalism, the data and the intelligence are all built around WA companies, people and projects — not adapted from a national feed. Data & Insights, included with every subscription, combines more than 30 years of WA-specific editorial research with live business data. There’s no comparable product for the WA market.

Advertisement

The Morning Digest Email provides a comprehensive wrap of the major headlines, relevant to WA business, and includes with a snapshot of the overnight news covering oil, gold and ASX-listed companies.

The Afternoon Wrap Email focuses on the news covered by our team of journalists during the course of the working day, including exclusive stories and analysis, all of which relates to WA business and the local economy.

The BN Weekender Email contains a wrap of the Business News from the week that was, highlighting the top stories in each area of WA business.
Sign up for free.

Advertisement

We’re happy to help.
Get in touch
and our team will come back to you.

Advertisement
Continue Reading

Business

Selena Gomez pushes back against ‘frivolous’ fraud claims

Published

on

The female and male characters from the new Grand Theft Auto 6 game.

The investors claim they were told that “Selena Gomez, one of the most famous women on earth, with a billion-dollar brand and a platform unmatched in social media, would be actively building the company as its head of marketing”.

Gomez’s attorney Matthew Rosengart says their allegations are “vague, generalised and contradictory” and that Gomez never agreed to, and did not, manage the company, or make the kind of commitments they are suggesting.

The emphatic pushback from Gomez may reflect a concern for her reputation but it also leaves her mother in the hot-seat, facing the fraud allegations alongside the company itself and a third co-founder.

Crisis PR commentator, Lauren Beeching, founder of Honest London says Gomez is far from the first celebrity to try working with a close family member. At times it can come off like in the Jenner-Kardashian household or with the tennis-playing Williams sisters.

Advertisement

But there are plenty of examples – from the Beckhams’ to Britney Spears – where family brands and business don’t mix well.

Working with close relatives, whether that’s a sibling or a parent, or someone else is almost always a higher risk approach, says Beeching.

“It can make the boundaries between the personal relationship with the business and the celebrity’s reputation much harder to separate,” she says.

The natural level of trust means that you might not apply the same rules as you would in a normal commercial relationhsip, so better guardrails are needed, she says.

Advertisement

“If you’re going into business [as a] family, I’d put more structure around it, not less, for sure.

“Define everybody’s responsibilities, bring in independent oversight, and decide what happens if something goes wrong before something goes wrong.”

“A family relationship shouldn’t be a company’s governance structure.”

At the end of the day Gomez may not need to worry too much over this case, says Beeching

Advertisement

“This will generate headlines because Selena Gomez is enormously famous, but I don’t think it’s the type of story her core audience is particularly interested in.

“There’s an important difference between generating negative headlines and causing lasting reputational damage. “

Still, for celebrities considering trading on their personal brand, she does have words of advice.

“Before lending your name to a company, don’t ask what your reputation could do for the business. Ask what that business can eventually do for your reputation as well.”

Advertisement
Continue Reading

Business

Wall Street gains as investors cheer Nvidia’s forecast

Published

on

Wall Street gains as investors cheer Nvidia's forecast

Yes. Corporate subscriptions are available for teams and organisations, with discounted rates as user numbers increase. Pricing starts from $1,625 + GST per user.
Get in touch
to discuss the right option for your organisation.

Business News subscriptions are used by executives, investors, consultants and professionals who need to stay informed and make better decisions about the WA market. When you subscribe you’ll get

  • Unlimited access to WA’s most trusted business journalism
  • Data & Insights — detailed profiles of WA companies, people, projects and deals
  • MyBN — a personalised feed based on the companies, people and sectors you follow
  • Special publications and industry reports
  • Daily and weekly email newsletters

Data & Insights is a research tool built specifically for the WA market. It draws on more than 30 years of Business News reporting, updated regularly to reflect what’s happening now. Use it to:

  • Look up detailed profiles of WA companies, including financials, directors and ownership
  • Find decision-makers and track their career movements
  • Research live and completed projects across WA industries
  • Monitor deals, appointments and market activity
  • Access industry rankings and league tables

Data & Insights is updated daily by our dedicated research team, which uses the latest announcements, ASX filings and editorial coverage to keep our person, company, list and project records up to date.

Business News welcome all opportunities to make our dataset accurate, complete and current, so if you have an update request, please email the team at
general@businessnews.com.au, and we’d be happy to assist.

Advertisement

MyBN
is part of every subscription. It’s your personalised view of Business News. You can follow the companies, people, sectors and projects that matter to you, and get a news feed and alerts tailored to your interests. You can save articles to read later and retain only what you need.

Only subscribers have full access to all content on the Business News website.

Advertisement

If staying informed about the WA economy is part of your job, and/or you’re looking for networking opportunities in WA, Business News is built for you.

Business News subscribers are:

  • Executives and directors tracking competitors, clients and market movements
  • Investors and advisers researching companies, deals and industry trends
  • Consultants and professionals staying across sectors relevant to their clients
  • Business owners looking for leads, context and market intelligence

Most Business News publications cover national or global markets. Business News is focused entirely on Western Australia, which means the journalism, the data and the intelligence are all built around WA companies, people and projects — not adapted from a national feed. Data & Insights, included with every subscription, combines more than 30 years of WA-specific editorial research with live business data. There’s no comparable product for the WA market.

Advertisement

The Morning Digest Email provides a comprehensive wrap of the major headlines, relevant to WA business, and includes with a snapshot of the overnight news covering oil, gold and ASX-listed companies.

The Afternoon Wrap Email focuses on the news covered by our team of journalists during the course of the working day, including exclusive stories and analysis, all of which relates to WA business and the local economy.

The BN Weekender Email contains a wrap of the Business News from the week that was, highlighting the top stories in each area of WA business.
Sign up for free.

Advertisement

We’re happy to help.
Get in touch
and our team will come back to you.

Advertisement
Continue Reading

Business

Mach7 FY26 slides: reset year delivers cost cuts, recurring revenue shift

Published

on


Mach7 FY26 slides: reset year delivers cost cuts, recurring revenue shift

Continue Reading

Business

CrowdStrike Stock Jumps 18% After Blowout Earnings Beat and Raised Guidance Fueled by AI Security Demand

Published

on

CrowdStrike Stock Jumps 18% After Blowout Earnings Beat and Raised

AUSTIN, Texas — Shares of cybersecurity firm CrowdStrike Holdings surged Thursday, climbing as much as 17.69% to $222.64, after the company delivered stronger-than-expected fiscal second-quarter results and raised its full-year outlook, capping off what its chief executive called the best quarter in the company’s history.

The stock jumped $33.46 in Thursday’s trading session, extending gains that began Wednesday evening after CrowdStrike released its earnings report. The rally came as part of a broader wave of enthusiasm for software and cybersecurity stocks, with peers Salesforce and Okta also posting double-digit gains following their own quarterly reports released the same evening.

A quarter that beat across the board

CrowdStrike reported fiscal second-quarter revenue of $1.47 billion, up roughly 26% from $1.17 billion a year earlier and above Wall Street’s consensus estimate of $1.44 billion. Adjusted earnings per share came in at 31 cents, topping analyst expectations of 29 cents. Free cash flow reached $377.4 million, ahead of the $353 million analysts had projected.

Advertisement

Net new annual recurring revenue, a closely watched measure of new business growth for subscription-based software companies, surged 51% to a record $333 million, prompting the company to raise its full-year net new ARR growth outlook by 630 basis points, according to 24/7 Wall St.

Chief Executive George Kurtz described the results in stark terms in the company’s earnings release. “The best quarter in CrowdStrike’s history,” Kurtz said, crediting the company’s positioning in the fast-growing market for AI-related cybersecurity threats.

Raised guidance for the year ahead

Building on the strong quarterly print, CrowdStrike lifted its full-year revenue guidance to a range of $5.99 billion to $6.01 billion, up from a prior midpoint of roughly $5.94 billion, while raising its adjusted earnings per share outlook to between $1.25 and $1.26. For the current quarter, the company guided toward revenue of $1.52 billion to $1.53 billion, also ahead of the $1.51 billion analysts had expected.

Advertisement

AI threats driving demand

Much of the enthusiasm around CrowdStrike’s results centered on the company’s positioning at the intersection of two major technology trends: the rapid adoption of artificial intelligence across enterprises, and the corresponding rise in security risks that adoption creates. As companies increasingly deploy AI agents and automated systems across their operations, demand has grown for tools capable of protecting those systems from emerging threats — a dynamic CrowdStrike executives say is playing directly into the company’s favor.

The company also highlighted strong growth in its Falcon Flex offering, a platform that allows customers to deploy and swap between different security tools as needed. According to the earnings call, Falcon Flex adoption more than doubled from the prior year, with the company adding 935 new Flex accounts during the quarter — accounts that comprised its top 10 deals by value. Finance chief Burt Podbere told analysts on the call that the Flex model was helping the company win larger, longer-term contracts by allowing customers to purchase multiple products under a single platform.

A stock already on a hot streak

Advertisement

Thursday’s jump adds to what had already been an exceptional year for CrowdStrike shares. Heading into the earnings report, the stock had gained more than 63% year-to-date in 2026, far outpacing the S&P 500’s roughly 12% advance over the same period, according to Yahoo Finance. Shares had briefly surpassed a record $225 earlier in August before pulling back to around $186 ahead of Wednesday’s report, according to the Motley Fool.

That run-up had raised questions among some investors about whether the stock’s valuation, trading at more than 150 times forward earnings heading into the report, had already priced in much of the company’s anticipated growth. Ahead of the release, analysts at firms including Scotiabank, KeyBanc, Robert W. Baird, Mizuho Securities and J.P. Morgan had raised their price targets on the stock, reflecting growing confidence in the company’s AI-driven cybersecurity momentum, even as some cautioned the shares looked more like a hold than an aggressive buy given the premium valuation.

Part of a broader earnings wave

CrowdStrike’s report landed alongside a cluster of other closely watched technology earnings releases Wednesday evening, most notably Nvidia’s own blockbuster results, which dominated investor attention during the after-hours session. Salesforce and identity-security firm Okta also posted strong beats that evening, with Okta shares spiking as much as 18% and Salesforce climbing more than 21% in premarket trading Thursday, according to FXStreet and Yahoo Finance.

Advertisement

The broader earnings season has been unusually strong across the board. According to data from FactSet cited by Yahoo Finance, second-quarter earnings for S&P 500 companies are on pace to grow 50% year over year, the fastest growth rate since 2021, with Bank of America strategists pointing to artificial intelligence as the primary engine behind that broad-based strength.

With CrowdStrike’s stock now trading well above levels seen just a day earlier, attention turns to whether the company can sustain the pace of growth reflected in Thursday’s raised guidance through the remainder of its fiscal year. Investors will be watching upcoming quarters for confirmation that the surge in AI-related security demand, and the accompanying growth in products like Falcon Flex, represents a durable long-term trend rather than a temporary spike tied to the broader wave of enterprise AI adoption sweeping across corporate America this year.

For now, Thursday’s rally reinforced a theme that has run through much of this earnings season: companies positioned to benefit from the operational and security demands created by rapid AI adoption are being rewarded handsomely by investors, even as questions persist about how long the current pace of growth, and the elevated valuations that have accompanied it, can be sustained.

Advertisement
Continue Reading

Business

FDA approves Gilead HIV pill Bixlenvo designed to simplify treatment

Published

on

FDA approves Gilead HIV pill Bixlenvo designed to simplify treatment

Gilead Bixlenvo drug

Courtesy: Gilead

The Food and Drug Administration approved a once-daily HIV pill from Gilead that could help simplify care for some patients, the company announced Thursday. 

Advertisement

The drug, marketed as Bixlenvo, is aimed at patients whose virus is already under control but who remain on complicated treatment regimens. It could also appeal to those who simply want to switch to a new treatment alternative.

The tablet combines bictegravir, the backbone of Gilead’s blockbuster HIV pill Biktarvy, with lenacapavir, a first-in-class capsid inhibitor that has become a centerpiece of the company’s long-term strategy for HIV treatment and prevention. 

The approval makes the new pill the first single-tablet regimen available for adults with HIV whose virus is suppressed but are unable to use currently available one-pill treatment options, according to Gilead. That population accounts for an estimated 5% or more of individuals in the U.S. living with HIV, the company told CNBC. 

The list price of the pill before discounts or rebates is $4,595 for a 30-day supply, which is in line with other daily single-tablet HIV treatments, Gilead told CNBC. People without health insurance may be eligible to get Bixlenvo for free through Gilead’s patient assistance program, while those with commercial or private insurance may be able to receive co-pay support through another savings program, the company said.

Advertisement

“It fulfills an unmet need, particularly for individuals who are on complex regimens who just would not otherwise consolidate down to something really meaningful for them and prescribers,” Dr. Jared Baeten, Gilead’s clinical development and virology therapeutic area head, said in an interview ahead of the approval. 

“But it’s also meaningful for individuals who are seeking options for something new,” he continued. “We want to build options that give people the opportunity to choose something that’s going to work for them and work for them for the long haul.”

There is no cure for HIV or AIDS. But many people living with HIV can manage the disease by taking a single pill daily, a treatment plan that Gilead helped pioneer two decades ago. 

But some patients can’t use any existing one-tablet options like Biktarvy and require more complex combinations of medicines because of drug resistance from older therapies, side effects or interactions with other drugs, among other treatment challenges. Those patients may have to take multiple pills a day and adhere to complicated dosing schedules.

Advertisement

Baeten said that group tends to be older and have long treatment histories, saying “some had to take handfuls of pills around 25 years ago.” HIV also accelerates complications of aging, such as heart disease, diabetes and high cholesterol, in that age group, he added. 

“It’s incredibly meaningful to develop a medicine, in my perspective, for people aging with HIV,” Baeten said. 

The new pill is also aimed at people who are doing well on a single-tablet regimen, including Biktarvy, and want to switch to a new one. Baeten stressed that Bixlenvo does not aim to replace Biktarvy. 

For patients already doing well on Biktarvy, the rationale for switching is more about expanding treatment choices, he said. He emphasized that HIV care is highly individualized and that long-term success often depends on finding a regimen that best fits a patient’s preferences and lifestyle.

Advertisement

Baeten also said Bixlenvo is part of Gilead’s broader effort to build a range of HIV treatment options around lenacapavir, including daily pills, weekly oral regimens and long-acting injectable therapies. The goal is to give patients flexibility to choose how they want to manage the disease, he said.

“We’re going to build enough options that people can make the choice that’s going to work for them,” Baeten said. “Some people like the surety of once a day, and some people would want ‘set it and forget it’ once every six months.”

What Bixlenvo is like for patients

Gilead Bixlenvo drug

Courtesy: Gilead

Advertisement

Baeten called it “essential” to have more than one medicine to treat HIV because the virus can become resistant to an initial treatment.

Combining bictegravir and lenacapavir in one pill allows it to “hit the virus in two different ways” with “high efficacy [and] strong protection” against the virus becoming resistant to treatment, Baeten added.

The approval is based on two Phase 3 trials, which evaluated Bixlenvo in adults with HIV whose virus was already suppressed on treatment. That includes people who switched from Biktarvy or complex treatment regimens with multiple tablets. 

The first trial – ARTISTRY-1 – specifically enrolled patients with long treatment histories and drug resistance, many of whom were taking multiple HIV medications each day. Participants had a median age of 60 and were taking between two and 11 pills daily before switching to Bixlenvo. 

Advertisement

In both studies, the pill maintained viral suppression at rates comparable to patients’ previous regimens at 48 weeks and was generally well tolerated with no new safety concerns. The most common side effects reported in at least 2% of participants across the two trials was headache, nausea and diarrhea. 

Timothy Cameron, a 64-year-old retired Seattle resident who has been living with HIV for more than 40 years, was among the participants in the first Phase 3 trial.

When he was first diagnosed in the 1980s, doctors had few treatment options and little ability to measure how active the virus was. He spent decades cycling through HIV medications, experimental drugs and multi-pill regimens that often came with difficult side effects and eventually stopped working against his “hard-to-treat” virus.

“It was just like throwing darts at a dartboard,” Cameron said. “Because I had done so many drug trials and monotherapy, my virus had become super resistant.”

Advertisement

A few years before enrolling in the Gilead study, Cameron finally found a regimen that controlled his virus, though it required taking one HIV pill twice daily along with another medication. His doctor encouraged him to join the trial and switch to Bixlenvo, a once-daily pill Cameron described as “smaller than my pinky nail.”

The transition was seamless, he said. The drug maintained control of his virus without causing side effects and simplified his treatment routine by reducing the number of pills he takes and consolidating all of his medications into a single daily schedule.

For Cameron, who spent decades exhausting HIV treatment options as his virus developed resistance, among the biggest benefits may be that the two-drug regimen effectively controls his virus while exposing him to fewer medications. He said that gives him confidence that additional treatment options could remain available in the future if he ever needs them.

“It’s one less thing I’m putting in my body, and it preserves options if I need them,” Cameron said.

Advertisement
Choose CNBC as your preferred source on Google and never miss a moment from the most trusted name in business news.
Continue Reading

Business

Pizza restaurants: Why pizza-making robots are not cutting it

Published

on

A robot arm hovers over a pizza

The robot pizza-making business has, it’s true, been littered with sorry tales of overcooked promises and melting fortunes. Besides Picnic, other companies that have come and gone include Zume, external and Pazzi, which used, external robot arms to assemble pizzas, as well as Basil Street, external, a purveyor of pizza vending machines.

Although so-called fast food might seem an easy target for automation, it’s proved harder than many expected. Plus, bringing robots into pizza restaurants could take away entry-level jobs in the hospitality sector. Is the future really filled with robotic pizza?

“We haven’t yet seen any of the success stories materialise the way some people thought they would,” admits Sara Senatore, senior restaurants analyst at Bank of America. Her employer has financial interests in multiple high street pizza chains including Papa Johns and Domino’s.

Food preparation bots are sometimes clumsy – dropping ingredients in the wrong places at times, she explains. Conversely, “Humans are very efficient at making pizza.”

Advertisement

But Kindell, despite his frustrations with Picnic, is surprisingly undeterred. He is a fan of full automation. “I want to be able to walk up to, let’s say, a type of kiosk, put in your order, and it makes a fresh pizza,” he tells the BBC.

Kindell, who once made all his dough by hand – until an elbow tendon injury forced him to investigate using machines instead, is now working on his own version of a pizza-making robot.

He declines to share details but the contraption will make square pan-style pies and that the machine is inspired by the way 3D printers work. If things go well, he says he could have a fully operational version of the device by the summer of 2027.

Given that he admits he has “no experience” in robotics, I question why he would want to invest in such a dicey business. Kindell says that failed pizza robot companies have nonetheless generated useful data and made strides in developing their technology. It’s just a matter of time before someone gets these things to work, he insists.

Advertisement

On jobs, he claims that even “fully autonomous” pizza robots won’t threaten workers. Kindell previously used Picnic’s robots at T-Mobile Park, home of the Seattle Mariners, a baseball team.

Usually, he’d need about 10 people to make pizza in such a setup. With the robots that number fell to just two. But the other eight people were still employed, he says, in roles where they interacted with customers, and advertised the pizza around the stadium.

“We had so many more people able to hand out the pizza,” says Kindell. “It was so much faster.”

Advertisement
Continue Reading

Business

The Big Four Recession Indicators: Real Personal Income

Published

on

The Big Four Recession Indicators: Real Personal Income

The Big Four Recession Indicators: Real Personal Income

Continue Reading

Business

An Oil Catastrophe Was Averted in 2026. What If It Comes in 2027?

Published

on

An Oil Catastrophe Was Averted in 2026. What If It Comes in 2027?

An Oil Catastrophe Was Averted in 2026. What If It Comes in 2027?

Continue Reading

Business

Wedding stationers not standing still

Published

on

Wedding stationers not standing still

Stationery vendors are adapting to a changing market driven by tech and cost-of-living pressures.

Continue Reading

Trending

Copyright © 2025